Brain Waste Clearance System Fails Earlier Than Expected in Psychosis

The glymphatic system — a brain-wide fluid transport network that clears metabolic waste during sleep and rest — has emerged as a critical player in neurodegeneration. Now, a 2025 study in Molecular Psychiatry provides the first evidence that this system is compromised in early psychosis, opening a new window into the disease's biological underpinnings.

Researchers from the University of Macau analyzed resting-state fMRI data from 137 young adults (average age ~24), including patients with early psychosis and healthy controls. They used BOLD-CSF coupling — the synchronized relationship between cortical blood-oxygen signals and ventricular cerebrospinal fluid flow — as a non-invasive marker of glymphatic clearance, a technique validated in neurodegenerative diseases like Alzheimer's.

Key results showed that BOLD-CSF coupling was both weaker in magnitude and more temporally delayed in early psychosis patients. The impairment was most prominent in high-order cortical regions (associated with complex cognition) rather than low-order sensory areas. Crucially, the degree of glymphatic dysfunction correlated with cognitive decline and severity of psychotic symptoms, suggesting clinical relevance beyond a mere imaging finding.

The study also found differences between affective and non-affective psychosis subtypes, hinting that glymphatic dysfunction may map onto distinct psychosis phenotypes. This parallels observations in Alzheimer's and Parkinson's disease, where compromised waste clearance accelerates toxic protein accumulation and neuroinflammation.

Caveats include reliance on an indirect fMRI proxy rather than direct glymphatic measurement, a cross-sectional design limiting causal inference, and a relatively small sample. Still, the identification of BOLD-CSF coupling as a potential biomarker for early psychosis could eventually guide earlier diagnosis and novel therapeutic strategies targeting brain fluid dynamics.